Contact
searchSearch
HMP Global

Gout News

Research Highlights
Nearly Half of Patients With Gout Have Metabolic Syndrome
03/18/2026
Jessica Garlewicz
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the...
03/18/2026
Rheumatology & Arthritis
Research Review
Gout and Psoriatic Disease Overlap Presents Diagnostic and Management Challenges
02/17/2026
Jessica Garlewicz
The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
The coexistence of gout and...
02/17/2026
Rheumatology & Arthritis
Research Highlights
Achieving Serum Urate Target Linked to Lower Cardiovascular Risk in Gout
02/17/2026
Jessica Garlewicz
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved...
02/17/2026
Rheumatology & Arthritis
Research Summary
Gout Associated With Higher Risk of Long-Term Opioid Use in Veterans Cohort
02/13/2026
Jessica Garlewicz
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Patients with gout are...
02/13/2026
Rheumatology & Arthritis
News
Treat-to-Target Urate-Lowering Therapy Improves Quality of Life in Gout
02/13/2026
Jessica Garlewicz
The findings provide patient-centered evidence supporting guideline-recommended, protocolized gout management.
The findings provide patient-centered evidence supporting guideline-recommended, protocolized gout management.
The findings provide...
02/13/2026
Rheumatology & Arthritis
Research Highlights
Emerging Microbiome Insights Suggest Novel Adjunct Targets in Gout Management
01/14/2026
Jessica Garlewicz
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links...
01/14/2026
Rheumatology & Arthritis
News
Febuxostat Linked to Higher Hepatotoxicity Risk Than Benzbromarone in Gout Patients
09/15/2025
Riya Gandhi, MA
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched...
09/15/2025
Rheumatology & Arthritis
News
Colchicine Drug Levels Not Predictive of Efficacy or Side Effects in Gout Flare Prevention
09/15/2025
Riya Gandhi, MA
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a...
09/15/2025
Rheumatology & Arthritis
Research Highlights
Only One-Third of Gout Flare Patients Follow Up After ED Visit, Study Finds
09/15/2025
Riya Gandhi, MA
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social...
09/15/2025
Rheumatology & Arthritis
News
Time Trends and Predictors of Gout Remission
09/04/2025
Rebecca Mashaw
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily...
09/04/2025
Rheumatology & Arthritis

Popular Articles

News
EULAR Updates Recommendations for PsA Management
06/17/2024

Jessica Garlewicz, Digital Managing Editor

Jessica Garlewicz, Digital Managing E...
The European Alliance of Associations for Rheumatology (EULAR) updated its 2019 guideline for the management of psoriatic arthritis to integrate new data and therapies.
The European Alliance of Associations for Rheumatology (EULAR) updated its 2019 guideline for the management of psoriatic arthritis to integrate new data and therapies.
The European Alliance of...
06/17/2024
Rheumatology & Arthritis
News
Therapeutic HCQ Levels Linked With Fewer Hospitalizations in Lupus
10/18/2024
Jessica Garlewicz
Nonadherence to receiving hydroxychloroquine is associated with a 3-fold higher risk of lupus-related hospitalization.
Nonadherence to receiving hydroxychloroquine is associated with a 3-fold higher risk of lupus-related hospitalization.
Nonadherence to receiving...
10/18/2024
Rheumatology & Arthritis
News
Unvaccinated Patients With Rheumatic Diseases Risked Severe COVID-19
08/07/2024
Rebecca Mashaw
Throughout the pandemic, patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes.
Throughout the pandemic, patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes.
Throughout the pandemic,...
08/07/2024
Rheumatology & Arthritis
News
MASLD Identified as Osteoarthritis Risk Marker in US Adults
05/03/2024
Jolynn Tumolo
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated...
05/03/2024
Gastroenterology
News
Oral Contraceptives May Protect Against Rheumatoid Arthritis
09/12/2024
Jessica Garlewicz
However, hormone replacement therapy was associated with a higher risk of late-onset RA, researchers found.
However, hormone replacement therapy was associated with a higher risk of late-onset RA, researchers found.
However, hormone replacement...
09/12/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use